Ipamorelin is a secretagogue peptide, meaning that can play a role in energy homeostatis as well as the regulation and control of body weight in animal test subjects. It is similar to the peptide GHRP-6, with one of the chief differences being that Ipamorelin is a penta-peptide as opposed to a hexa-peptide. In other words, the peptide consists of five sides instead of six. It is considered to be an agonist, meaning that it has the capability to bind to certain receptors of a cell and induces a cellular response. The peptide is administered to animal test subjects via subcutaneous injection as part of ongoing scientific research in relation to studying its operational mechanisms and properties.
The Fuctionality of Ipamorelin
According to scientific research conducted on animal test subjects, the primary function of Iparmorelin is to stimulate the pituitary gland. This is the pea-sized gland found at the base of the brain that is responsible for regulating an organism’s endocrine-based functionality. These various functions include:
- Regulation of bodily growth
- Regulation of hyroid gland function
- Regulation of blood pressure
- Pain relief
- Regulation of temperature
Part of Ipamorelin’s functionality is that it stimulates the production of a hormone that is secreted by the pituitary gland of animal test subjects. At the same time, the Ipamorelin has been shown through scientific research conducted on animal test subjects to inhibit the production of somatostatin; a peptide that is chiefly responsible for blocking the release of some hormones. Additionally, the peptide has been shown to increase the production of IGF-1. This hormone, also known as Insulin-Like Growth Factor 1 or somatomedin C, is similar in the molecular build of insulin which is secreted in animal test subjects as an endocrine hormone, which through scientific research as determined to be the chief anabolic mechanism of action for some hormones. This portion of the peptide’s functionality makes it similar to the operational tendencies of GHRP-6. However, unlike the GHRP-6, Ipamorelin works to bind to major control points of appetite, gastric, and growth motility. In other words, scientific research on animal test subjects have determined that the peptide does not induce an increase in hunger levels, which has been determined to be an effect found in GHRP-6.
Scientific studies on animal test subjects also show that Ipamorelin does not significantly increase the production levels of cortisol; the hormone found in animal test subjects that increases blood sugar through the process of gluconeogenesis. It also does not significantly increase the production levels of prolactin; the hormone that is plays an important role in regulating the immune system of animal test subjects, primarily as it relates to the process of lactation.
Benefits of Ipamorelin
Scientific research that has been conducted on animal test subjects has determined several different theoretical benefits that have been linked to Ipamorelin. These theoretical benefits include:
- Increased fat loss
- Rejuvenation of joints
- Strengthening of joints
- Strengthening of connective tissue
- Strengthening of bone mass
- Improved skin tone
These types of positive benefits have led some scientific studies to determine that the peptide could carry several theoretical benefits as they relate to the slowing down of the aging process.
Side Effects of Ipamorelin
The negative side effects of Ipamorelin, according to scientific research that has been conducted on animal test subjects, are determined to be minimal. These negative side effects primarily have been known to consist of headaches and head rushes (also referred to as a feeling of light-headedness). The research that has been conducted on animal test subjects has determined that these side effects are relatively mild in nature. Furthermore, the list of negative side effects has been determined to be significantly shorter than the list of side effects that are typically associated with the peptide GHRP-6.
For Clinical Research Only
While scientific study conducted on animal test subjects have determined a basic outline relating to the operational mechanisms and functionality of Ipamorelin, it should be noted that work with the peptide is still currently confined to the research stage. Any positive benefits or negative side effects that have been documented through scientific research on animal test subjects is still a product of research that is still ongoing and not conclusive. Therefore, it is crucial to note that any observation or findings regarding Ipamorelin in relation to its overall mechanisms, operational properties, positive benefits, or negative side effects should be contained to the confines of a strictly controlled environment such as a laboratory or a research facility.